EditorialFree Access
Do stem cell-derived islets represent a commercially viable treatment for Type 1 and 2 diabetes?
Published Online:17 Nov 2010https://doi.org/10.2217/rme.10.75
Bibliography
- 1 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group: Modern-day clinical course of Type 1 diabetes mellitus after 30 years’ duration. Arch. Intern. Med.169,1307–1316 (2009).
- 2 Robertson RP: Islet transplantation a decade later and strategies for filling a half full glass. Diabetes59,1285–1291 (2010).
- 3 Fiorina P, Shapiro AMJ, Ricordi C, Secci A: The clinical impact of islet transplantation. Am. J. Transplant.8,1990–1997 (2008).
- 4 Thompson DM, Begg IS, Harris C et al.: Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy. Transplantation85,1400–1405 (2008).
- 5 Tharavanij T, Betancourt A, Messinger S et al.: Improved long-term health-related quality of life after islet transplantation. Transplantation86,1161–1167 (2008).
- 6 Nierras CR, Stallard J, Goldstein RA, Insel R: Human embryonic stem cell research and the Juvenile Diabetes Research Foundation International – a work in progress. Pediatr. Diabetes5(Suppl. 2),94–97 (2004).
- 7 Aguayo-Mazzucato C, Bonner-Weir S: Stem cell therapy for Type 1 diabetes mellitus. Nat. Rev. Endocrinol.6,139–148 (2010).
- 8 McKernan R, McNeish J, Smith D: Pharma’s developing interest in stem cells. Cell Stem Cell6,517–520 (2010).
- 9 Borowiak M, Melton DA: How to make β cells? Curr. Opin. Cell Biol.21,727–732 (2009).
- 10 Puri S, Hebrok M: Cellular plasticity within the pancreas – lessons learned from development. Dev. Cell18,342–356 (2010).
- 11 Jiang J, Au M, Lu K et al.: Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells25,1940–1953 (2007).
- 12 D’Amour KA, Bang AG, Eliazar S et al.: Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol.24,1392–1401 (2006).
- 13 Kroon E, Martinson LA, Kadoya K et al.: Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol.26,443–452 (2008).
- 14 Placzek MR, Chung IM, Macedo HM et al.: Stem cell bioprocessing: fundamentals and principles. J. R. Soc. Interface6,209–232 (2009).
- 15 McCall MD, Toso C, Baetge EE, Shapiro AM: Are stem cells a cure for diabetes? Clin. Sci.118,87–97 (2009).
- 16 Vendrame F, Pileggi A, Laughlin E et al.: Recurrence of Type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic CD4 T-cells. Diabetes59,947–957 (2010).
- 17 Korsgren O, Nilsson B: Improving islet transplantation: a roadmap for widespread application for the cure of persons with Type 1 diabetes. Curr. Opin. Organ Transplant.14,683–687 (2009).
- 18 Beckwith J, Nyman JA, Flanagan B et al.: A health-economic analysis of porcine islet xenotransplantation. Xenotransplantation17,233–242 (2010).
- 19 O’Connell P: The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in Type 1 diabetes – chapter 6: patient selection for pilot clinical trials of islet xenotransplantation. Xenotransplantation16,249–254 (2009).
- 101 Centers for Disease Control and Prevention: National Diabetes Fact Sheet www.cdc.gov/diabetes/pubs/general07.htm#what
- 102 American Diabetes Association: the cost of diabetes www.diabetes.org/advocate/resources/cost-of-diabetes.html
- 103 Next generation β-cell transplantation www.niddk.nih.gov/fund/other/nextgenbeta/
- 104 Baker M, Carpenter M: Making stem cells for many, safely. Nature Reports Stem Cells www.nature.com/stemcells/2009/0908/090827/full/stemcells.2009.113.html
